NCI | Technology Transfer

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

The Netherlands
18782605.2
Filed on 2018-09-17

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Switzerland
18782605.2
Filed on 2018-09-17

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Ireland
18782605.2
Filed on 2018-09-17

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

United Kingdom
18782605.2
Filed on 2018-09-17

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Belgium
18782605.2
Filed on 2018-09-17

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Germany
18782605.2
Filed on 2018-09-17

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

Read more about METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION

France
18782605.2
Filed on 2018-09-17

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Australia
2025203455
Filed on 2025-05-13

DRUG-REGULATABLE, INDUCIBLE CYTOKINE EXPRESSION

Read more about DRUG-REGULATABLE, INDUCIBLE CYTOKINE EXPRESSION

Patent Cooperation Treaty
PCT/US2025/031121
Filed on 2025-05-28

Glypican 2 As A Cancer Marker And Therapeutic Target

Read more about Glypican 2 As A Cancer Marker And Therapeutic Target

Japan
2025-034156
Filed on 2025-03-05

Subscribe to NCI